TODD STRATEGY GROUP

Lobbying for GLAXOSMITHKLINE LLC · Pharmaceutical Company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medicare/Medicaid

Medicare and Medicaid issues. 340B Issues.

Health Issues

Drug pricing. Implementation of IRA. Supply chain issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.